Skip to main content

Table 6 Patients with thromboembolic events

From: Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants

  Age Gender CHA2DS2-VASc Anticoagulation Clinic CT Scan Other Diagnosis
Patient 1 65 female 2 DOAC/Rivaroxaban Temporary paraesthesia of the right leg No signs of stroke MRI: herniation LS 4/5 Puncture related paraesthesia OR TIA
Patient 2 52 male 0 DOAC/Rivaroxaban Visual impairment 24 postprocedural
Restitutio after 3 h
No signs of stroke Duplex: no pathology TIA
Patient 3 45 male 2 DOAC/Apixaban Visual impairment No signs of stroke Opth: Choroidal nevus TIA
Patient 4 73 female 3 DOAC/Apixaban Visual impairment No signs of stroke Duplex: no pathology TIA
Patient 5 52 male 2 Bridging Visual impairment No signs of stroke Duplex: no pathology TIA
Patient 6 72 female 3 VKA Visual impairment No signs of stroke Duplex: no pathology TIA
Patient 7 71 male 3 VKA Hemianopsia Signs of stroke   Stroke of the posterior cerebral artery
Patient 8 47 male 0 VKA Aphasia Signs of stroke   Stroke right frontal operculum
  1. Legend: Bridging interrupted vitamin-K-antagonist, DOAC uninterrupted non-vitamin-K anticoagulants, VKA uninterrupted vitamin-K-antagonist